Oncolytics Biotech, Inc. (ONCY)
0.9901
-0.01
(-0.83%)
USD |
NASDAQ |
Dec 12, 16:00
0.9901
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Gross Profit (TTM): -0.2731M for Sept. 30, 2025
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 236.39M |
| Edesa Biotech, Inc. | -0.1376M |
| Lexaria Bioscience Corp. | 0.6154M |
| Xenon Pharmaceuticals, Inc. | 4.935M |
| ProMIS Neurosciences, Inc. | 0.00 |